Working with PolyNovo

The PolyNovo business model has two aspects:

  • Licensing the NovoSorbTM technology to device manufacturers
  • Developing devices with lower regulatory requirements

Licences:

NovoSorbTM is currently licensed in the following fields

  • Orthopaedic

- Fracture Fixation  (Smith and Nephew)

- Bone void filler (Smith and Nephew)

  • Wound management

Joint Ventures:

NovoSkin and NovoWound are two joint ventures between PolyNovo Pty Ltd and Skin Pty Ltd (80-20) developing devices for the burn and wound markets.

To discuss a licence or a development opportunity please contact us at info@polynovo.com